Tokyo, Apr 28, 2004 (JCN) - Yakult Honsha has announced that it has agreed with OncoTherapy Science to collaborate in R&D in the field of antibody drugs for cancer treatments.
Under this alliance, the two companies will strive to develop new antibody drugs aimed at the treatment of lung cancer.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
|